Latest Licensing News

Elevra Lithium's updated scoping study for its North American Lithium mine expansion reveals a faster ramp-up to 338 ktpa spodumene concentrate with stable costs and a significant increase in project value.

4DS Memory is accelerating commercialisation of its 60nm ReRAM technology in India, aligning with the country’s AUD$25 billion semiconductor investment and targeting mature-node industrial and defence sectors.

Critical Resources has launched a systematic field exploration program at the Corona Pegmatite Field, aiming to expand its lithium resource pipeline within the Mavis Lake Project in Ontario, Canada.

Bioxyne has locked in a two-year, $50 million exclusive supply agreement with German pharmaceutical distributor ADREXpharma, granting exclusive rights to its Dr Watson® brand in Germany and reinforcing its foothold in Europe’s largest medicinal cannabis market.

Temas Resources’ 2026 re-assays of 2022 drill samples at La Blache reveal material uplifts in vanadium, gallium, scandium, and chromium grades, strengthening the case for its proprietary Regenerative Chloride Leach technology.

Embark Early Education delivered solid 2025 growth with revenue up 28% to $104.7 million and Centre EBITDA rising 16%, while advancing its strategic stake in Mayfield Childcare to nearly 50%.

Cash Converters reports solid 1H26 results driven by a growing loan book, expanding luxury retail footprint, and increased corporate store ownership across 15 countries.

Adisyn’s subsidiary 2D Radar has teamed with Israeli plastics giant Raval to fast-track graphene-enhanced stealth parts for drones, aiming to compress development-to-production timelines from years to months.

Spenda Limited has sold its Ledger platform to APG Pay for $1.8 million, cutting $2.7 million in annual costs and streamlining operations to concentrate on its core revenue-generating products.

Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.

Xenitra Limited has secured $1.25 million through a share placement to accelerate its OTC medicines rollout and expand its OPAL RWA token ecosystem, with shareholder approval pending for attached options.

ARN Media reported a 10% revenue decline in FY25 but accelerated digital growth and cost savings, while defending ongoing legal disputes with former talent.